Key result
Shenmai injection combined with western medicine improved the clinical effective rate compared to western medicine alone in patients with chronic heart failure.
Why the study?
Does the addition of Chinese herbal injections to western medicine improve clinical effective rate and LVEF in patients with chronic heart failure?
Meta-Analysis (n=9,525)
Does the addition of Chinese herbal injections to western medicine improve clinical effective rate and LVEF in patients with chronic heart failure?
The addition of Shengmai or Shenmai injections to standard western medicine may improve clinical symptoms and left ventricular ejection fraction in patients with chronic heart failure.
Answers are grounded in this paper and cite their sources.
Supports adjunctive Shenmai in chronic heart failure; extends network meta-analysis evidence for traditional Chinese medicine.
BACKGROUND: On account of deterioration of chronic heart failure (CHF) and extensive exploration of Chinese herbal injections (CHIs), we performed a network meta-analysis to investigate the efficacy of CHIs (Huangqi injection, Shenfu injection, Shengmai injection, Shenmai injection, Shenqi Fuzheng injection, Yiqifumai injection) on the basis of western medicine (WM) treatment in CHF. METHODS: Literature search was conducted in Embase, the Cochrane Library, Pubmed, Chinese Biological Medicine Database, China National Knowledge Infrastructure, Wanfang Database, Chinese Scientific Journal Database from inception to June 12nd 2017, and study selection was abided by a prior eligible criteria. RESULTS: Ultimately, a total of 113 randomized controlled trials (RCTs) were enrolled. The clinical data of the effective clinical rate, left ventricular ejection fraction, cardiac output and others outcomes was estimated by Stata software and Winbugs software. Risk of bias was assessed by Cochrane Collaboration's tools. Integrating the each outcome's results, a combination of Shengmai injection/Shenmai injection and WM obtain a first rank in most outcomes, particularly primary outcomes. CONCLUSIONS: In conclusion, on the basis of WM, Shengmai injection or Shenmai injection may be a perforable treatment in CHF. In terms of insufficient of this study, more high quality RCTs needed to implement to support our conclusions.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted a meta-analysis in Chronic heart failure (CHF) (n=9,525). Shenmai injection (SMI) or Shengmai injection (SI) vs. Western medicine (WM) alone was evaluated on Clinical effective rate (OR 0.25, 95% CI 0.17-0.36). Shenmai injection combined with western medicine improved the clinical effective rate compared to western medicine alone in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: